Robeco Institutional Asset Management B.V. Sage Therapeutics, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$45.4 Billion
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$27.52 - $37.99 $399,342 - $551,272	-14,511 Closed	0 $0
Q1 2022 Dec 01, 2022	SELL	$30.71 - $45.71 $633,209 - $942,494	-20,619 Reduced 58.69%	14,511 $480,000
Q1 2022 Apr 26, 2022	SELL	$30.71 - $45.71 $633,209 - $942,494	-20,619 Reduced 58.69%	14,511 $480,000
Q4 2021 Dec 01, 2022	BUY	$37.06 - $47.11 $279,135 - $354,832	7,532 Added 27.29%	35,130 $1.49 Million
Q4 2021 Jan 31, 2022	BUY	$37.06 - $47.11 $279,135 - $354,832	7,532 Added 27.29%	35,130 $1.49 Million

Q3 2021 Dec 01, 2022	BUY	$40.26 - $57.37 $985,766 - $1.4 Million	24,485 Added 786.54%	27,598 $1.22 Million
Q3 2021 Oct 20, 2021	BUY	$40.26 - $57.37 $985,766 - $1.4 Million	24,485 Added 786.54%	27,598 $1.22 Million
Q2 2021 Dec 01, 2022	BUY	$54.88 - $79.29 $170,841 - $246,829	3,113 New	3,113 $177,000
Q2 2021 Jul 28, 2021	BUY	$54.88 - $79.29 $170,841 - $246,829	3,113 New	3,113 $177,000

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

Vanguard Group Inc Valley Forge, PA

5.75M
Shares

$62 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.48M
Shares

$59.1 Million
1.65% of portfolio
Black Rock Inc. New York, NY

4.89M
Shares

$52.7 Million
0.0% of portfolio
Wellington Management Group LLP Boston, MA

4.75M
Shares

$51.2 Million
0.02% of portfolio
State Street Corp Boston, MA

4.49M
Shares

$48.5 Million
0.0% of portfolio

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account